DR Corporation (301177) Fair Value & Analysis
Consumer Cyclical · CN · Market cap 10.6B CNY
Fair value as of: Jul 9, 2026
From 13 valuation models · updated 32 days ago
Share price −0.5% over the past month.
Below-average quality, and screening another 77% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (¥6.91). The favourable scenario is already priced in.
- Weak quality (44/100) and above fair value at the same time, the margin of safety is missing on both counts.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 9, 2026.
How to read this chart
56‑month range ¥16.82 – ¥146.74 · fair‑value band ¥4.43 – ¥6.91 · the ¥23.25 price screens above the ¥5.26 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 9, 2026.
Analysis
DR Corporation (301177) currently trades at ¥23.25, while our model-based Fair Value estimate is ¥5.26, implying the stock looks roughly 77.4% overvalued today. The Quality Score stands at 44/100 (below-average quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, DR Corporation generated revenue of 1.5B CNY at a net margin of 10.6%. Revenue declined 11.4% year over year. It earns a return on equity of 2.4%. Net debt stands at 535M CNY. Fundamentals as of Jul 9, 2026
Our scenario range runs from ¥4.43 (bear case) to ¥6.91 (bull case); at ¥23.25, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 46% below its 52-week high and 3% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Cyclical peers we cover trades at -41% fair-value upside, at -77%, 301177 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 13 models by family
Widest divergence: Asset-Based (¥10.49) versus DCF Models (¥1.12). Highest evidence: Residual Income (76).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 9, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 42 · Market factors (momentum, volatility) 26
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
DR Corporation Limited engages in the design and marketing of high-end engagement rings and fine jewelry worldwide. The company offers engagement rings, wedding rings, anniversary gifts, and bridal gold collections. It sells its products under the DR Diamond Ring brand through online and offline stores.
Full company description
DR Corporation Limited engages in the design and marketing of high-end engagement rings and fine jewelry worldwide. The company offers engagement rings, wedding rings, anniversary gifts, and bridal gold collections. It sells its products under the DR Diamond Ring brand through online and offline stores. The company was founded in 2010 and is based in Shenzhen, China. DR Corporation Limited is a subsidiary of Shenzhen DR Investment Co., Ltd.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
DR Corporation reported revenue of ¥1.5B in FY2025 versus ¥4.6B in FY2021, a compound −24.3%/yr. Reported net income was ¥139M in FY2025, compounding −42.8%/yr from FY2021.
301177 screens 77% overvalued. Compare with Compagnie Financière Richemont SA →
Peer Group
Luxury Goods · 132 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Luxury Goods median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Insider activity: 45/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Luxury Goods stocks, each showing price versus our Fair Value estimate (as of Jul 9, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Compagnie Financière Richemont SA CFR | CHF 197.40 | CHF 117.30 | -41% |
| Christian Dior SE DIO | €455.40 | €502.30 | +10% |
| Kering SA KER | €248.50 | €60.61 | -76% |
| Tapestry, Inc TPR | $140.73 | $19.95 | -86% |
| Chow Tai Fook Jewellery Group 1929 | HK$11.82 | HK$12.28 | +4% |
| The Swatch Group UHRN | CHF 40.95 | CHF 21.48 | -48% |
| Prada S.p.A 1913 | HK$43.26 | HK$64.05 | +48% |
| Pandora A/S PNDORA | kr 779.40 | kr 1,424 | +83% |
| Brunello Cucinelli S.p.A BC | €80.32 | €42.69 | -47% |
| Kalyan Jewellers India Limited KALYANKJIL | ₹546.60 | ₹238.57 | -56% |
Compare DR Corporation with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Cyclical stocks →
Frequently asked questions
Is DR Corporation (301177) overvalued or undervalued?
What is the fair value of 301177?
What is the quality score of 301177?
What is the revenue of DR Corporation (301177)?
What is the net profit margin of 301177?
Does DR Corporation pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track DR Corporation and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.